https://www.edumaterial.bayer.eg/en 2024-11-13T13:41:54+00:00 daily 1.0 https://www.edumaterial.bayer.eg/ar/eg-privacy-policy 2024-02-15T13:34:33+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-privacy-policy 2024-02-15T13:31:34+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-cookies-and-disclaimer 2025-02-28T09:52:36+00:00 0.5 https://www.edumaterial.bayer.eg/ar/eg-imprint 2025-04-29T12:44:57+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-imprint 2025-04-29T12:43:12+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-eylea-pg 2026-03-09T11:40:46+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg 2024-02-26T10:45:26+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-eylea-pg/instructions-for-use-handling-2 2021-02-03T14:32:59+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-eylea-pg/after-the-injection-2 2021-02-03T14:34:39+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-eylea-pg/adverse-drug-reactions-2 2021-02-03T14:35:27+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/patient-alert-card-2 2024-02-26T10:47:07+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/dosing-in-patients-with-atrial-fibrillation 2024-02-26T10:48:25+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/pci-stent-placement 2021-01-21T14:32:52+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/dosing-in-treatment-of-deep-vein-thrombosis-dvt-and-pulmonary-embolism-pe-and-prevention-of-recurrent-dvt-and-pe-in-adults 2024-02-26T10:50:04+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/prevention-of-atherothrombotic-events 2024-02-26T10:54:59+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/prevention-of-atherothrombotic-events-in-adult-patients-after-an-acute-coronary-syndrome-acs-with-elevated-cardiac-biomarkers 2024-02-26T10:57:03+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/prevention-of-vte-in-adult-patients-undergoing-elective-hip-or-knee-replacement-surgery 2024-02-26T10:58:29+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/oral-intake-2 2024-02-26T10:59:38+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/perioperative-management-2 2024-02-26T11:01:21+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/spinalepidural-anaesthesia-or-puncture-2 2024-02-26T11:04:18+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/converting-from-vka-to-xarelto 2024-02-26T11:19:03+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/converting-from-xarelto-to-vka 2024-02-26T11:30:51+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/converting-from-parenteral-anticoagulants-to-xarelto 2024-02-26T11:34:46+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/converting-from-xarelto-to-parenteral-anticoagulants 2024-02-26T11:41:25+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/populations-potentially-at-higher-risk-of-bleeding-2 2024-02-26T11:43:18+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/other-contraindications 2024-02-26T11:46:13+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/overdose-2 2024-02-26T11:51:00+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/coagulation-testing-2 2024-02-26T11:52:26+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/appropriate-local-safety-information-2 2024-02-26T11:53:33+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-xarelto-pg/dosing-overview 2024-02-26T11:55:19+00:00 0.5 https://www.edumaterial.bayer.eg/en/end-navigation 2021-03-16T14:34:34+00:00 0.5 https://www.edumaterial.bayer.eg/ar/eylea-patient-ar 2025-03-18T11:38:57+00:00 0.5 https://www.edumaterial.bayer.eg/en/eylea-patient-en 2025-02-28T10:31:43+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-mirena-pg 2025-02-28T09:42:39+00:00 0.5 https://www.edumaterial.bayer.eg/ar/eg-about 2025-04-29T12:53:51+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-about 2025-04-29T12:52:16+00:00 0.5 https://www.edumaterial.bayer.eg/ar/eg-contact 2025-04-29T12:49:03+00:00 0.5 https://www.edumaterial.bayer.eg/en/eg-contact 2025-04-29T12:47:22+00:00 0.5